Current care strategies for Duchenne muscular dystrophy [Aktuelle Betreuungsstrategien bei Duchenne-Muskeldystrophie]

被引:0
|
作者
Fujak A. [1 ]
Haaker G. [1 ]
Funk J. [1 ]
机构
[1] Orthopädische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Deutschland, Rathsberger Str. 57, Erlangen
来源
Der Orthopäde | 2014年 / 43卷 / 7期
关键词
Kontrakturen; Skoliose; Behandlung; Orthopädietechnische Hilfsmittel; Rehabilitation; Contractures; Scoliosis; Treatment; Orthopedic technical aids; Rehabilitation;
D O I
10.1007/s00132-013-2217-7
中图分类号
学科分类号
摘要
BACKGROUND: The medical care of patients with Duchenne muscular dystrophy (DMD) is an interdisciplinary and multifaceted task. The vast majority of those affected show a nearly constant course which is reflected in a corresponding stage-oriented treatment concept. Although there is still no causal therapy available for DMD, the course and in particular the quality of life of patients can be decisively improved by established medical practices.THERAPEUTIC STRATEGIES: The orthopedic problems of DMD patients include contractures of the upper and lower extremities as well as sitting instability due to progressive scoliosis with pelvic imbalance. The orthopedic treatment incorporates conservative measures, such as physiotherapy, provision of orthotic devices and wheelchairs as well as surgery to resolve contractures of the lower extremities and surgical stabilization of the spine. Furthermore, in these patients orthopedic surgeons and trauma surgeons are confronted with the treatment and prophylaxis of fractures induced by osteoporosis. An early onset of glucocorticoid therapy markedly delays the loss of motor abilities.TREATMENT ASPECTS: An important aspect in the care of DMD patients is the timely prophylaxis and treatment of respiratory insufficiency with regular sessions of breathing therapy, learning breathing and coughing techniques and the sufficiently early start of non-invasive mechanically assisted ventilation. Of similar relevance are also the early recognition and cardioprotective treatment of cardiomyopathy.CONCLUSION: The orthopedic surgeon accompanies the patient and family through all stages of the disease and must be appropriately informed on current management and treatment strategies even outside the limits of the personal field of specialization.
引用
收藏
页码:636 / 642
页数:6
相关论文
共 50 条
  • [1] Duchenne-Muskeldystrophie
    Thomas Meißner
    MMW - Fortschritte der Medizin, 2015, 157 (13) : 81 - 81
  • [2] Current care strategies for Duchenne muscular dystrophy
    Fujak, A.
    Haaker, G.
    Funk, J.
    ORTHOPADE, 2014, 43 (07): : 636 - 642
  • [3] Current Pharmacological Strategies for Duchenne Muscular Dystrophy
    Yao, Shanshan
    Chen, Zihao
    Yu, Yuanyuan
    Zhang, Ning
    Jiang, Hewen
    Zhang, Ge
    Zhang, Zongkang
    Zhang, Baoting
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [4] Wirbelsäulendeformität bei Muskeldystrophie Typ DuchenneSpinal deformity in Duchenne muscular dystrophy
    Ralf Stücker
    Sebastian Stücker
    Kiril Mladenov
    Der Orthopäde, 2021, 50 (8): : 638 - 642
  • [6] Interaktiver Online-Kurs: Duchenne-Muskeldystrophie
    Facharztmagazine R.
    MMW - Fortschritte der Medizin, 2022, 164 (Suppl 4) : 50 - 50
  • [7] Current and emerging treatment strategies for Duchenne muscular dystrophy
    Mah, Jean K.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1795 - 1807
  • [8] Kennen Sie die Zeichen der Duchenne-Muskeldystrophie?
    Facharztmagazine R.
    MMW - Fortschritte der Medizin, 2023, 165 (Suppl 1) : 50 - 50
  • [9] Therapeutic strategies for Duchenne muscular dystrophy
    不详
    DRUG NEWS & PERSPECTIVES, 2005, 18 (08) : 517 - 518
  • [10] Wie geht es den Kindern mit Duchenne-Muskeldystrophie?
    Pädiatrie & Pädologie, 2021, 56 : 148 - 149